WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 1110

Legislative bill overview

HB 1110 relates to medical cannabis policy in Hawaii, though the specific provisions are not detailed in the available legislative record. The bill was introduced by Representative Nadine Nakamura and has progressed through initial readings before being carried over to the 2026 legislative session for further consideration.

Why is this important

Medical cannabis legislation affects patient access to treatment options, regulatory frameworks, and potential tax revenue for the state. Hawaii's approach to medical cannabis can influence healthcare delivery, law enforcement priorities, and interstate commerce considerations in a region with significant tourism and military presence.

Potential points of contention

  • Scope of qualifying conditions – Disagreement likely exists over which medical conditions justify cannabis access and whether the list should expand beyond current state provisions
  • Regulatory oversight and licensing – Debate over which agencies should regulate production, distribution, and dispensing, and what compliance standards should apply
  • Banking and tax implications – Federal prohibition creates complications for financial services and tax treatment that may generate political disagreement over state-level solutions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.